the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Official Title A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients With Triple Negative Breast Cancer: Hoosier Oncology Group BRE12-158
Principal Investigator Nanda, Rita
Brief Summary This study will test the theory that therapy designed for each individual's tumor will improve outcomes over standard of care in a population that needs a better standard.
Gender Both
Ages 18 Years
Enrollment 136
Accepts Healthy Volunteers No
Lead Sponsor Bryan Schneider, MDOther
Collaborator Hoosier Cancer Research NetworkOther
Study Design Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Study Phase Phase 2
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Malignant Neoplasm of Breast
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI